Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters
Open Access
Abstract
Background: The Hippo signaling pathway, a highly conserved regulatory cascade, regulates tissue homeostasis, organ size, and tumor suppression. Dysregulation of this pathway contributes to oncogenesis in various human malignancies; however, its clinicopathologic relevance in cervical cancer has not been completely elucidated. Therefore, this study aimed to investigate the expression patterns of key Hippo pathway proteins and analyze their associations with tumor behavior and clinicopathologic features in cervical carcinoma. Materials and Methods: Ninety-nine cervical cancer specimens obtained from hysterectomies performed at Gyeongsang National University Hospital (2012–2019) were retrospectively analyzed. Immunohistochemical staining for Yes-associated protein (YAP), phosphorylated YAP (p-YAP), mammalian sterile-20-like kinase-1 (MST1), and large tumor suppressor kinase-1 (LATS1) was performed on tissue microarrays. Chi-square or Fisher’s exact tests and logistic regression were employed for assessing associations between marker expression and clinicopathologic variables. Functional validation was conducted via small interfering RNA-mediated YAP knockdown in Caski cervical cancer cells, with reverse transcription-polymerase chain reaction, Western blotting, and wound-healing assays assessing YAP suppression and cell migration. Results: YAP and p-YAP were expressed in 71.8% and 62.6% of tumors, respectively; MST1 in 82.8%; and LATS1 in 22.2%. YAP and p-YAP overexpression was correlated with larger tumor size (p = 0.013 and p = 0.011) and higher International Federation of Gynecology and Obstetrics stage (p = 0.007 and p < 0.001). YAP and p-YAP expression was positively correlated (odds ratio, 4.34; 95% confidence interval, 1.70–11.61). MST1 or LATS1 expression demonstrated no significant associations. In vitro, YAP silencing decreased mRNA and protein expression levels and significantly impaired cell migration, supporting its role in tumor aggressiveness. Conclusions: YAP and p-YAP overexpression are associated with advanced stage and larger tumor size in cervical cancer, indicating Hippo pathway dysregulation. YAP functional suppression attenuated migratory capacity, highlighting YAP as a promising prognostic biomarker and therapeutic target.Keywords
Funding Information
- Biomedical Research Institute Fund (GNUCHBRIF-2025-0006)
- Korea government (RS-2023-00213650)
This publication has 45 references indexed in Scilit:
- Cancer of the cervix uteri: 2025 updateInternational Journal of Gynecology & Obstetrics, 2025
- Study of the TEAD-binding domain of the VGLL1, VGLL2 and VGLL3 proteins from vertebratesArchives of Biochemistry and Biophysics, 2024
- Therapeutic targeting of TEAD transcription factors in cancerTrends in Biochemical Sciences, 2023
- New insights in Hippo signalling alteration in human papillomavirus-related cancersCellular Signalling, 2020
- The Hippo Pathway, YAP/TAZ, and the Plasma MembraneTrends in Cell Biology, 2020
- Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic OpportunitiesTrends in Cancer, 2019
- AJUBA increases the cisplatin resistance through hippo pathway in cervical cancerGene, 2018
- Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast CancerJournal of Cellular Physiology, 2017
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerCell, 2015
- The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAPCell, 2005